tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Stock News & Sentiment

Compare
90 Followers
Barinthus Biotherapeutics Restructures to Focus on Immunotherapy
Premium
Company Announcements
Barinthus Biotherapeutics Restructures to Focus on Immunotherapy
2M ago
Barinthus Biotherapeutics Appoints New Chief Scientific Officer
Premium
Company Announcements
Barinthus Biotherapeutics Appoints New Chief Scientific Officer
4M ago
Barinthus Biotherapeutics Reports Promising IM-PROVE II Trial Results
Premium
Company Announcements
Barinthus Biotherapeutics Reports Promising IM-PROVE II Trial Results
4M ago

News Score - Last 7 Days

Neutral
BRNS
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average53%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BRNS’s Media Buzz Sentiment?
1 articles about BRNS were published this week. In an average week, 1 articles are published.
    What is BRNS’s weekly average amount of articles?
    In an average week, 1 articles about BRNS are published.
      What is BRNS’s News Sentiment?
      50% of articles about BRNS were positive this week, compared to its sector average of 53%.
        Healthcare Stocks that are Trending in the News
        JAZZJazz Pharmaceuticals
        NVONovo Nordisk
        FENCFennec Pharmaceuticals
        CKPTCheckpoint Therapeutics
        JNJJohnson & Johnson
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis